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Shigella flexneri causes human dysentery after invading the cells of the colonic epithelium. The best-studied
effectors of Shigella entry into colonocytes are the invasion plasmid antigens IpaC and IpaB. These proteins are
exported via a type III secretion system (TTSS) to form a pore in the host membrane that may allow the
translocation of other effectors into the host cytoplasm. TTSS-mediated secretion of IpaD is also required for
translocation pore formation, bacterial invasion, and virulence, but the mechanistic role of this protein is
unclear. IpaD is also known to be involved in controlling Ipa protein secretion, but here it is shown that this
activity can be separated from its requirement for cellular invasion. Amino acids 40 to 120 of IpaD are not
essential for IpaD-dependent invasion; however, deletions in this region still lead to constitutive IpaB/IpaC
secretion. Meanwhile, a central deletion causes only a partial loss of control of Ipa secretion but completely
eliminates IpaD’s invasion function, indicating that IpaD’s role in invasion is not a direct outcome of its ability
to control Ipa secretion. As shigellae expressing ipaD N-terminal deletion mutations have reduced contact-
mediated hemolysis activity and are less efficient at introducing IpaB and IpaC into erythrocyte membranes,
it is possible that IpaD is responsible for insertion of IpaB/IpaC pores into target cell membranes. While
efficient insertion of IpaB/IpaC pores is needed for optimal invasion efficiency, it may be especially important
for Ipa-dependent membrane disruption and thus for efficient vacuolar escape and intercellular spread.
Shigella flexneri is a facultative intracellular bacterial patho-
gen responsible for shigellosis, a mild to severe gastrointestinal
syndrome with worldwide occurrence (11). Invasion of colonic
epithelial cells is a required step in the pathogenesis of shig-
ellosis, as these cells provide the primary site for pathogen
multiplication, and it has been shown that mutations rendering
the bacterium noninvasive eliminate its virulence potential (11,
35). The protein effectors of enterocyte invasion by Shigella
invasion are the invasion plasmid antigens (Ipa proteins); how-
ever, invasion is also dependent upon the production of Ipa-
specific chaperones and a type III secretion system (TTSS)
composed of the Mxi/Spa secretion apparatus or secreton (4).
TTSS-dependent integration of the hydrophobic proteins IpaB
and IpaC into the host cell plasma membrane following patho-
gen contact is essential for triggering the actin reorganization
that precedes S. flexneri entry into enterocytes (3, 36). The
globular and hydrophilic protein IpaD is also secreted by the
Shigella TTSS and is required for bacterial invasion of host
cells; however, little is known of the role IpaD plays in Shigella
invasion of human colonic epithelial cells (17, 22, 38).
Prior to pathogen contact with a host cell, IpaB and IpaC are
stored in the Shigella cytoplasm, where they independently
associate with the chaperone IpgC, which prevents their pre-
mature association (23) and may queue them for proper se-
cretion (2). Following their secretion, IpaB and IpaC form a
pore-like complex (3) within the host cell membrane to trigger
bacterial uptake by macropinocytosis (3, 7, 12, 20, 23) and to
serve in the translocation of other effectors (e.g., IpaA and
IpgD) into the target cell cytoplasm (4). Both IpaB and IpaC
have been implicated in directly triggering signal transduction
cascades in target cells that lead to apoptosis in macrophages
(6) and cytoskeletal rearrangements in macrophages (16) and
epithelial cells (18, 20, 35, 36). Insertion of the IpaB-IpaC
translocon into a target cell membrane requires bacterial con-
tact, but this insertion event appears to be largely cell type
independent as all mammalian cell types thus far tested in vitro
can be invaded by shigellae, including neuronally derived cells
(J. C. Osiecki and W. D. Picking, unpublished results). Like-
wise, S. flexneri inserts the IpaB-IpaC translocon into red blood
cells (RBC), where many of the characteristics of these pores
were first described (3). Because of this, contact-dependent
osmotic lysis of RBC has provided a valuable tool for moni-
toring the formation and function of the S. flexneri translocon
(31).
No direct effector activity has ever been specifically associ-
ated with IpaD; however, this protein is required for the inva-
sion and contact-mediated hemolysis activities of S. flexneri
(22). Terajima and coworkers have described experiments in
which all three essential Ipa effectors (IpaB, IpaC, and IpaD)
must be preincubated with HeLa cells to induce the uptake of
noninvasive Escherichia coli K-12 (34) and IpaD may be re-
quired, with IpaB and IpaC, for Ipa complex association with
51 integrins in vitro (39). In another report, IpaD has been
described as being a regulator of Ipa protein secretion as a
nonpolar ipaD null mutant constitutively secretes the remain-
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ing Ipa proteins, as well as approximately 15 other proteins
(21). IpaD has also been found in a complex with IpaB within
bacterial membrane fractions and was therefore postulated to
serve as part of a “plug” that prevents excessive and/or pre-
mature secretion of IpaB and IpaC prior to contact with a
target eukaryotic cell (21). It is possible that parts of IpaD may
be exposed on the surface of S. flexneri as part of this role (38).
It was also found that an ipaD nonpolar mutant strain was
incapable of inserting IpaB and IpaC into host membranes, but
this effect could not be dissociated from the deregulated se-
cretion of IpaB and IpaC that this mutant also displayed (3,
21). Thus, the relevance of constitutive Ipa protein secretion to
the loss of Shigella invasiveness has yet to be tested. Compar-
isons between the Ipa-dependent invasion mechanism of shi-
gellae and the Salmonella invasion protein (Sip)-dependent
invasion of eukaryotic cells by Salmonella enterica suggest a
similar role for SipD, which has some sequence similarity to
IpaD (15). However, the effect of SipD-dependent control of
effector secretion on Salmonella invasion has yet to be clearly
described.
While type III secretion has come to be known as a shared
property of many gram-negative pathogens of animals and
plants, the mechanistic subtleties by which the different TTSSs
insert translocation proteins (or, in the case of shigellae, trans-
location-effector proteins) into the host cytoplasmic membrane
continues to evade description (4, 14). One of the mysterious
features of Shigella invasion of eukaryotic cells is the require-
ment for IpaD, a protein whose role in pathogen uptake ap-
pears to be linked to its ability to prevent IpaB and IpaC
secretion. In this report, the role of IpaD in the interaction of
shigellae with target cells is explored in detail.
MATERIALS AND METHODS
Materials. S. flexneri strain M90T was provided by E. V. Oaks (Walter Reed
Army Institute for Research) and grown at 37°C on Trypticase soy agar contain-
ing 0.025% Congo red. S. flexneri mutant strains SF621 and SF622 (nonpolar
ipaC and ipaD mutants, respectively) were from P. J. Sansonetti (Institut Pas-
teur) (22). Specific Ipa protein monoclonal antibodies, rabbit antisera, and the
baby hamster kidney (BHK) cell line were from E. V. Oaks (37, 38). S. flexneri
mxiD (1) mutant BS612 and mxiM mutant BS547 were provided by A. T. Mau-
relli (Uniformed Services University of the Health Sciences) (33). Plasmid
pKLP103 was provided by B. D. Jones (University of Iowa) for the expression of
sipD, the Salmonella homologue of ipaD, in S. flexneri SF622 (28). Plasmid
pWPsfc (for ipaC expression) was described in previous work (30). Henle 407
cells (ATCC CCL6) were propagated as monolayers in Eagle’s modified minimal
essential medium (MEM; Fisher Scientific, St. Louis, Mo.) supplemented with
10% newborn calf serum (Life Technologies, Gaithersburg, Md.) and grown in
5% CO2. PCR SuperMix High Fidelity, and oligonucleotides were from Invitro-
gen (Carlsbad, Calif.). Clonables 2X Ligation Premix and competent E. coli
NovaBlue were from Novagen (Madison, Wis.). Sheep RBC were from Colorado
Serum Co. (Denver, Colo.) or TCS Biosciences (Buckingham, United Kingdom).
Polyethylene glycol (PEG) of all sizes was from Fluka (Buch SG, Switzerland).
All other chemicals were reagent grade.
Generation of ipaD deletion mutations for expression in S. flexneri SF622. The
plasmids used in this work are listed in Table 1. Expression plasmid pWPsf4 is a
pUC18 derivative that has an NdeI site inserted so that translation starts with the
Met encoded by the NdeI site (12). The ipaD gene was subcloned from pET15b
into the NdeI/BamHI sites of pWPsf4 as previously described for other con-
structs (30). The resulting plasmid, pWPsf4D, was introduced into S. flexneri
ipaD mutant strain SF622 by electroporation. All ipaD deletion mutations were
made by inverse PCR with pWPsf4D as the template and primers composed of
GAGAGA, an XhoI or BamHI restriction site, and 18 nucleotides flanking the
region to be deleted. The desired linear plasmid was amplified by PCR, digested
with BamHI or XhoI, intramolecularly ligated, and transformed into E. coli
NovaBlue. The resulting plasmid was introduced into S. flexneri SF622 by elec-
troporation. Ampicillin selection ensured the presence of the recombinant plas-
mid while kanamycin resistance and/or Congo red binding ensured the presence
of the S. flexneri virulence plasmid.
To prepare IpaDSC321AS, the substitution of AlaSer for SerCys at 321, a 5
primer containing GAGAGA, an NheI site (encoding AlaSer), and 18 bases 5
of codon 321 and a 3 primer containing GAGAGA, an NheI site, and 18 bases
3 of codon 322 were used with pWPsf4D as the template in an inverse PCR. The
product was digested, intramolecularly ligated, and used to transform E. coli
NovaBlue. The resulting plasmid was introduced into S. flexneri SF622 by elec-
troporation. Ampicillin selection ensured the presence of the recombinant plas-
mid, while kanamycin resistance and/or Congo red binding ensured the presence
of the S. flexneri virulence plasmid.
Assay of bacterial entry into cultured epithelial cells. S. flexneri invasion of
Henle 407 cells was monitored with a gentamicin protection assay as previously
described (27, 30). Henle 407 cells were seeded into 24-well plates and grown
overnight to form preconfluent monolayers. SF622 harboring the desired plasmid
was grown in Trypticase soy broth (TSB) containing 100 g of ampicillin per ml
and 50 g of kanamycin per ml to an A600 of 0.4 to 0.6. The bacteria were diluted
into serum-free MEM containing 0.45% glucose, centrifuged onto the surface of
semiconfluent Henle 407 monolayers at a multiplicity of infection of 10 to 100,
and incubated with the cells for 30 min at 37°C. Free bacteria were removed by
aspiration, and the monolayers were washed with MEM containing 5% calf
serum and 50 g of gentamicin per ml. The cells were incubated in the final
gentamicin wash for 1 h to kill adherent but noninternalized bacteria and then
rinsed with MEM–0.45% glucose. The cells were lysed by overlaying them with
250 l of 0.5% agarose in water. The solidified agarose was then overlaid with
0.5% agar containing 2 Luria-Bertani medium. After overnight incubation at
37°C, internalized bacteria formed subsurface colonies that were readily counted.
Alternatively, the host cells were lysed following a 30-min invasion with a 20-min
gentamicin incubation, and dilution plating was used to quantify the number of
viable, internalized bacteria. A shorter gentamicin wash was used with this assay
so that enumeration of bacteria that had invaded could be done with minimal
interference caused by bacterial intracellular multiplication.
As an additional measure of invasion, plaque assays were performed as de-
scribed by Oaks and colleagues (26). These allowed assessment of both quanti-
tative and qualitative aspects of invasion—particularly intercellular spread,
which could be influenced by altered vacuolar escape. Briefly, early log phase
bacteria were diluted and added to preconfluent BHK cell monolayers, which
were then incubated at 37°C in a humidified 5% CO2 environment for 90 min. An
overlay composed of high-glucose Dulbecco modified Eagle medium with 5%
calf serum, 20 g of gentamicin per ml, and 0.5% SeaKem ME agarose was
added to the monolayers, which were further incubated for 48 h. A second
overlay composed of high-glucose Dulbecco modified Eagle medium with 20 g
of gentamicin per ml, 0.5% SeaKem ME agarose, and 0.01% neutral red was
added. The plaques were then monitored for size after an additional 24 h of
incubation.
Measurement of Ipa protein secretion by S. flexneri. Ipa protein secretion was
measured by enzyme-linked immunosorbent assay (ELISA) as previously de-
scribed (12). Briefly, bacteria were grown to an A600 of 0.5 to 0.8 and 10 ml of the
culture was centrifuged for 10 min at 4,500  g. The bacterial pellet was resus-
TABLE 1. Plasmids used in this study
Plasmid Protein encoded Reference
pWPsf4 None 12a
pWPsf4D IpaD This work
pWPsf4D6 IpaD1–20 This work
pWPsf4D910 IpaD41–80 This work
pWPsf4D1112 IpaD81–120 This work
pWPsf4D1314 IpaD121–160 This work
pWPsf4D1516 IpaD161–180 This work
pWPsf4D1718 IpaD201–240 This work
pWPsf4D1920 IpaD241–280 This work
pWPsf4D2122 IpaD281–320 This work
pWPsf4D23E IpaD321–332 This work
pWPsf4D5E IpaD328–332 This work
pWPsf4Dcys IpaDSC321AS This work
pWPsfc IpaC 30
pKPL103 SipD 28
a pWPsf4 was derived from pUC18 for specific expression of ipa genes in
S. flexneri as described by Harrington et al. (12).
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pended in 400 l of 0.1 M carbonate, pH 9, and the cells were lysed by sonication
(15 s, 40% power) to release cytoplasmic IpaD or IpaC. The culture supernatant
was the source of secreted IpaD or IpaC. Each antigen source was diluted 1:3
with carbonate buffer, and 100 l was used to coat the wells of a polystyrene
96-well microtiter plate overnight in preparation for a standard ELISA. IpaC or
IpaD in the bacterial cytoplasm was detected by preparing cell lysates, separating
the cell-associated proteins by sodium dodecyl sulfate (SDS)-polyacrylamide gel
electrophoresis (PAGE), and monitoring for the presence of IpaC or IpaD by
immunoblot analysis with anti-IpaC or anti-IpaD monoclonal or polyclonal an-
tibodies, respectively. Constitutive secretion of IpaB, IpaC, and IpaD was deter-
mined by precipitating the proteins present in the overnight culture supernatants
of bacteria grown in TSB and separating the total proteins from equal amounts
of bacteria by SDS-PAGE, followed by Coomassie blue staining. Relative
amounts of IpaB and IpaC present in culture supernatant samples were deter-
mined by densitometric scans of Coomassie-stained gels with the Alpha Innotech
(San Leandro, Calif.) Chemi-Imager system. Relative amounts of IpaD in culture
supernatants were also assessed by immunoblot analysis with anti-IpaD poly-
clonal antibodies.
Measurement of contact-mediated hemolysis. Contact-mediated hemolysis
was measured as described by Sansonetti’s group (3, 31). Briefly, S. flexneri was
grown overnight on Trypticase soy agar-Congo red plates and a single red colony
was used to inoculate TSB. The bacteria were grown to mid-log phase, and the
cells were collected by centrifugation and resuspended in phosphate-buffered
saline (PBS) at 1/40 of the original volume. Sheep RBC were washed and re-
suspended in PBS at a concentration of 1010/ml. RBC and bacteria (50 l each)
were added to wells of microtiter plates, and the plates were centrifuged at
2,200  g for 15 min at 20°C. The plates were then incubated at 37°C for 2 h. The
cells were resuspended by adding 90 l of cold PBS, and the plates were cen-
trifuged again at 2,200  g and 15°C for 15 min. The supernatant fraction (100
l) was transferred to a second microtiter plate, and the A545 of the released
hemoglobin was measured with a microtiter plate reader. The negative control
for hemolysis (to establish a baseline value) was PBS, and the positive control (to
give 100% hemolysis) was water, which resulted in complete release of hemo-
globin because of osmotic lysis of the RBC.
Osmoprotection of RBC. To determine the size of IpaB/IpaC pores inserted
into erythrocyte membranes, osmoprotection experiments were carried out as
previously described (3). RBC that had been incubated with bacteria were re-
suspended in PBS or in PBS containing 60 mM PEG400, PEG600, PEG1000,
PEG1500, PEG2000, or PEG3000 and incubated at 37°C. The samples were
cooled, resuspended, and immediately recentrifuged. The amount of hemolysis
was then measured by spectrophotometric determination of the amount of re-
leased hemoglobin as described above.
Measurement of association of IpaB and IpaC with RBC membranes after
hemolysis. After scaled-up hemolysis reactions, 800 l of water was added to
each sample to lyse all of the RBC that might have remained intact so that
membrane-associated proteins could be determined, as described previously (3).
Briefly, the lysed RBC were centrifuged to remove bacteria and 2 ml of the
supernatant was removed and made to 2.4 ml with TBS. This sample was then
made to 46% sucrose by adding 7 ml of 62% sucrose in TBS containing protease
inhibitors. These samples were overlaid with 2 ml of 44% sucrose and then 25%
sucrose, both in TBS. The step gradients were centrifuged at 15,000  g for 16 h
at 4°C. The material at the 44 to 25% sucrose interface was collected, diluted
with TBS, and concentrated by centrifugation at 450,000  g for 20 min at 4°C.
The pellet was resuspended in SDS sample buffer, and equal amounts of total
protein were separated by SDS-PAGE. IpaB or IpaC was then detected by
immunoblot analysis with anti-IpaB or anti-IpaC antibodies. Protein concentra-
tions were determined by the method of Bradford (5).
RESULTS
IpaD possesses distinct functional domains. To explore the
functional relevance of IpaD in S. flexneri invasion, a series of
deletion mutations spanning nearly the entire length of ipaD
was generated and each was inserted into pWPsf4 (Table 1).
These plasmids were introduced into S. flexneri ipaD mutant
SF622. All ipaD mutants were expressed at roughly equal lev-
els, as determined by immunoblot analysis of whole-cell ex-
tracts (Fig. 1). Next, the ability of the mutants to restore inva-
sion-related functions was monitored. The data, summarized
in Table 2, suggest a distinct functional organization for IpaD.
As expected on the basis of available information on other
TTSS substrates (12, 14), deletion of the first 20 amino acids of
IpaD gives rise to a protein that does not appear to be secreted
by the TTSS and does not restore invasiveness or contact-
mediated hemolysis activity to SF622 (Table 2) but is readily
detected in bacterial cell lysates by immunoblot analysis (Fig.
1). It is likely that a general signal for IpaD secretion via the
TTSS is encoded within the first 15 amino acids of the protein
because these IpaD residues are sufficient to restore secretion
and invasion function to an IpaC derivative that has had its first
20 amino acids removed (12). No other deletions that are down-
stream of the first 40 amino acids have a negative effect on
IpaD secretion (Table 2; Fig. 1); however, in order to distance
the deletions introduced here from the identified IpaD secre-
tion signal, it was decided to begin the 40-amino-acid deletions
at residue 40. In ongoing experiments, it has been noticed that
deletion of residues 31 to 40 has little or no impact on IpaD
function while deletion of residues 21 to 30 may influence IpaD
synthesis or stability (A. Olive, K. Flentie, and W. L. Picking,
unpublished results).
When different 40-amino-acid deletions were introduced be-
ginning at residue 41, it was found that amino acids 41 to 80
(IpaD41-80) and 81 to 120 (IpaD81-120) could be removed
with no negative effect on IpaD-dependent invasion function,
as determined by a gentamicin protection assay that uses a
Luria-Bertani agar overlay, followed by counting of subsurface
bacterial colonies (Table 2). However, expression of these
FIG. 1. The IpaD deletion mutations are synthesized in S. flexneri
SF622, and all but IpaD1–20 are secreted into the bacterial culture
supernatant (CS). Overnight cultures were used to prepare culture
supernatants and whole-cell extracts (WCE). The presence or absence
of IpaD was then determined by immunoblot analysis. The antibodies
used were a mixture of rabbit antisera (numbers 18, 20, and 23) gen-
erated against three different IpaD-derived peptides composed of
amino acids 55 to 70, 102 to 115, and 280 to 295 (38) that were derived
from different regions of the protein so that they could recognize all of
the deletion mutations described here. The negative control for pro-
duction of IpaD was S. flexneri SF622 harboring pWPsf4 (no ipaD
insert), and the negative control for secretion was S. flexneri BS547
(lacking a functional TTSS). Positive controls for synthesis and secre-
tion were wild-type S. flexneri M90T and SF622 harboring pWPsf4D
(for expressing a wild-type copy of ipaD). The relative amount of IpaD
either synthesized or secreted was roughly estimated on the basis of the
intensity and size of the resulting IpaD bands. A nonspecific band
present in the whole-cell extracts (indicated by the asterisk) provides a
crude control for protein loading, while equal volumes of culture su-
pernatant were loaded onto the culture supernatant lanes. The bands
corresponding to IpaD321–332 and IpaD328–332 migrate slower than
the other IpaD deletion mutant proteins because they have only 12 and
5 amino acids deleted, respectively (arrows). The complete experiment
was performed in toto twice (with most parts being performed at least
three times) with identical results.
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ipaD deletion mutations in SF622 did result in a decrease in
the efficiency with which shigellae lysed RBC (Table 2). Be-
yond amino acid 120, all of the deletions introduced into IpaD
eliminate its ability to restore invasion and contact-mediated
hemolysis functions to Shigella strain SF622 (Table 2). Even
additional small deletions introduced at or near the IpaD C
terminus, as seen for IpaD328-332, eliminate its ability to re-
store invasiveness and contact-mediated hemolysis activity to
SF622 (Table 2). Interestingly, these C-terminal mutations re-
sult in the secretion of large amounts of IpaD (Fig. 1), while
steady-state levels of IpaD within the bacteria apparently re-
main the same as in wild-type bacteria (Fig. 1). Moreover, the
wild-type ipaD gene restores efficient invasion to SF622, and
ipaD possessing a substitution mutation that eliminates a cys-
teine residue near the C terminus, which has been observed to
lead to dimerization of recombinant IpaD in vitro, restored
invasion activity to a higher level than did wild-type IpaD
(Table 2).
Interestingly, when bacterial invasion of cultured cells was
quantified by lysing the host Henle 407 cells following a 20-min
gentamicin wash and counting the released bacteria by dilution
plating, shigellae expressing ipaD41-80 and ipaD81-120 both
appeared to invade at lower levels than shigellae expressing
ipaD (41 and 21%, respectively,  10%; n 	 3). These invasion
data more closely parallel the contact-mediated hemolysis data
given in Table 2. To allow determination of whether the ex-
pression of ipaD41-80 or ipaD81-120 influences the ability of
shigellae to spread to adjacent cells, invasion activity was de-
termined by a plaque assay with BHK cells used as host cells
(28). This assay also indicated that the invasion activity of
SF622 cells expressing ipaD41-80 and ipaD81-120 was reduced
(Table 3), but to a lesser extent than when it was measured by
releasing the intracellular bacteria (see above). However, it
was interesting that while the sizes of the plaques formed by
the ipaD41-80 mutant were indistinguishable from those formed
by SF622 expressing wild-type ipaD and by wild-type strain
M90T, those formed by the ipaD81-120 mutant were approxi-
mately 25% smaller than those produced by SF622 expressing
either wild-type ipaD or ipaD41-80 and nearly 30% smaller
than those produced by M90T (Table 2). These data suggest
that the lower level of contact-mediated hemolysis observed
for SF622 expressing ipaD81-120, but not ipaD41-80, has an
impact on the intercellular spread of this bacterium, as might
be expected if it were experiencing difficulty in vacuolar escape
either during the initial invasion event or during spread to ad-
jacent cells. Interestingly, none of the deletion mutations tested
had a dominant negative effect when introduced into wild-type
shigellae (data not shown), suggesting that their possible in-
teractions with other proteins do not interfere with the func-
tion of the wild-type IpaD protein already made by these cells.
All deletions introduced into IpaD resulted in increased
secretion of IpaC. Because the only role for IpaD described to
date that relates to Shigella invasion of target cells is its ability
to control the secretion of IpaB and IpaC (21), each of the
mutations described in Table 2 was tested for the ability
to prevent the constitutive secretion of IpaC that occurs in
S. flexneri ipaD mutant SF622. SF622 harboring the different
ipaD-containing pWPsf4 constructs was grown overnight in
TSB, and the resulting culture supernatants were tested for the
relative levels of IpaC present by ELISA (Fig. 2). As expected,
the absence of IpaD gave rise to increased levels of IpaC de-
tected in culture supernatants, and this increase in IpaC secre-
tion could be eliminated when SF622 was transformed with
pWPsf4 expressing wild-type ipaD (Fig. 2). Interestingly, all of
the ipaD deletion mutants gave rise to an apparent IpaC-
TABLE 2. Abilities of IpaD deletion mutations to restore
invasiveness and contact-mediated hemolysis






SF622 (ipaD) 0.1  0.2e 0.0  0e 

M90T 123  12 100  5 
BS547 (mxiM) 0.0  0e 0.0  0e 

IpaD 100  16 100  0.1 
IpaD1–20 0.0  0e 0.0  0e 

IpaD41–80 95.0  15 47  5f 
IpaD81–120 101.0  11 32  2f 
IpaD121–160 1.0  1e 0.0  0e 
IpaD161–180 3.0  0.2e 0.0  0e 
IpaD201–240 1.0  0.4e 0.0  0e 
IpaD241–280 3.0  0.2e 0.0  0e 
IpaD281–320 0.1  0.2e 0.0  0e 
IpaD321–332 3.0  0.1e 0.0  0e 
IpaD328–332 0.1  0.1e 0.0  0e 
IpaDSC321AS 147  10 100  0.1 
SipD 0.0  0e 0.0  0e Not done
a Strains that have IpaD or an IpaD deletion mutation listed are actually
S. flexneri SF622 (a nonpolar ipaD mutant) expressing the gene for that particular
IpaD derivative.
b Restoration of invasion is presented relative to invasion by SF622 trans-
formed with pWPsf4D  the standard deviation (n 	 3). The data shown are
from one of three representative experiments.
c Contact-mediated hemolysis is presented as a percentage of complete hemo-
lysis, such as that which occurs upon the addition of water (n 	 3 from one of five
representative experiments).
d IpaD secretion was measured by a semiquantitative ELISA system (n 	 5)
with overnight culture supernatants (also see Fig. 1). The antibodies used here
were a mixture of rabbit antisera (numbers 18, 20, and 23) generated against
three different IpaD-derived peptides composed of amino acids 55 to 70, 102 to
115, and 280 to 295 (38) that were derived from different regions of the protein
so that they could recognize all of the deletion mutations described here. Whole
bacterial lysates were also used to determine whether the IpaD derivatives
described here were similarly synthesized (Fig. 1). 
, no secretion; , normal
secretion; , increased secretion.
e P  0.001 by a paired Student t test.
f P  0.05 by a paired Student t test.
TABLE 3. Plaque size on BHK cell monolayers for S. flexneri
SF622 expressing ipaD, ipaD41–80, or ipaD81–120
Strain Relative invasion (%)a Plaque size (mm)b
None 0.0  0 NAc
M90T 115  7 1.28  0.23
BS547 (mxiM) 0.0  0 NA
ipaD 100  10 1.21  0.51
ipaD41–80 68  17d 1.18  0.15
ipaD81–120 48  13d 0.91  0.08d
a Invasion is shown relative to that of SF622 expressing wild-type ipaD and
with a multiplicity of infection of 1 in six-well tissue culture plates. The data
shown are averages of three measurements from a single representative exper-
iment.
b Plaque size was determined on day 4 following a 3-day incubation of bacteria
with BHK cells and including a 1-day incubation in the presence of neutral red
(average  standard deviation obtained with 15 randomly selected plaques in
each of two independent experiments).
c NA, not applicable because the complete absence of invasion did not give rise
to observable plaques.
d P  0.06 by the paired Student t test.
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constitutive secretion phenotype, even those that restored in-
vasiveness and a substantial portion of the contact-mediated
hemolysis activity to SF622 (Table 2). In each case, the amount
of IpaC made in these mutants was largely unchanged as de-
tected by ELISA and immunoblot analysis with whole-cell ly-
sates (data not shown), indicating that altered expression of
ipaC was probably not influencing the invasion data.
Constitutive secretion of IpaC and IpaB by SF622 express-
ing different ipaD deletion mutations. Although the 40-amino-
acid deletions near the IpaD N terminus do not eliminate
invasion and contact-mediated hemolysis, they do lead to a
marked increase in IpaC secretion, as determined by ELISA
analysis (Fig. 2). This increase in the secretion of IpaC appears
to be nearly equal to that seen in the ipaD null mutant. To
examine this more carefully, SF622 expressing the different
ipaD deletion mutations were grown overnight and the pro-
teins present in equal amounts of culture supernatant were
trichloroacetic acid precipitated and separated by SDS-PAGE.
After Coomassie staining, the resulting gels corroborate the
data obtained by ELISA analysis by showing that all of the
deletions introduced into IpaD result in the constitutive secre-
tion of both IpaB and IpaC (Fig. 3). In fact, the magnitude of
this constitutive secretion event appears more pronounced
when determined by SDS-PAGE (Fig. 3) than it does when
determined by ELISA (Fig. 2). Once again, even the IpaD mu-
tants capable of restoring efficient invasiveness and a substan-
tial amount of contact-mediated hemolysis activity to SF622
allow constitutive secretion of IpaB and IpaC (Fig. 3). These
data show that the IpaB/IpaC constitutive-secretion phenotype
observed in SF622 bacteria is not responsible per se for their
inability to invade cultured cells. These data again indicate that
IpaD’s role in Shigella invasion is more complex than sim-
ply controlling Ipa protein secretion. Interestingly, when a
20-amino-acid deletion is introduced near the middle of IpaD
(e.g., IpaD161–180), much of the control of IpaB and IpaC
secretion is restored; however, this does not correspond to any
level of restoration of either invasion or contact-mediated he-
molysis activity (Fig. 3 and Table 2). This finding also implies
that IpaD’s ability to control Ipa protein secretion alone does
not explain the importance of IpaD in Shigella invasion of
enterocytes.
A subtle but possibly significant observation related to the
constitutive secretion of Ipa proteins allowed by the different
IpaD deletion mutations is that the ratio of IpaB and IpaC
found in culture supernatants appears to vary somewhat de-
pending upon the location of the deletion introduced into
IpaD. For IpaD41–80 and IpaD81–120, the amount of IpaC in
the Shigella culture supernatants appears to exceed the amount
of IpaB on the basis of Coomassie blue staining (Fig. 3). How-
ever, this trend seems to reverse itself as the mutations are
introduced nearer to the C terminus of IpaD (Fig. 3). These
differences in the ratio of IpaC to IpaB are subtle, but they are
reproducible and can be quantified by densitometric analysis.
The ratio of IpaB to IpaC, on the basis of densitometry, is 0.7
to 0.8 for the IpaD41–80 and IpaD81–120 mutants but in-
creases to 1.3 to 1.8 for the remainder of the deletion mutants
(and the parent ipaD mutant SF622) described in Fig. 3. When
one considers the relative sizes of IpaB and IpaC (approxi-
mately 62 versus 42 kDa, respectively), the change in ratio
between the two becomes even more striking. Assuming equiv-
alent Coomassie staining, the estimated IpaB/IpaC molar ratio
is 0.5 for the IpaD41–80 and IpaD81–120 mutants, while it is
0.9 to 1.22 for the other IpaD deletion mutants. The low level
of IpaB and IpaC secretion by SF622 expressing wild-type ipaD
prevented making such measurements for this Shigella strain.
These findings may implicate IpaD not only in controlling
FIG. 2. Secretion of IpaC is increased in S. flexneri expressing mu-
tant forms of ipaD. An ELISA was used to allow initial detection of
IpaC quantities in the culture supernatants of S. flexneri strain SF622
expressing ipaD harboring different deletions. The primary antibody
used here was a mouse monoclonal antibody that recognizes an epi-
tope precisely mapped to the central hydrophilic region of IpaC (37).
All analyses were performed in triplicate and are presented as an
average  standard deviation (n 	 5) from one of two nearly equal ex-
periments in which the upper limit with respect to linearity for the IpaC
protein is approached but not exceeded. On the basis of rough stan-
dard curves with purified recombinant IpaC, all of the values observed
for the detection of IpaC are within the linear range of detection by
this ELISA system, although the higher IpaC values are near the upper
range of linear detection. The asterisks indicate P values (Student t test)
of 0.10.
FIG. 3. SDS-PAGE analysis of IpaB and IpaC secreted into culture
supernatants by SF622 expressing different ipaD deletion mutations.
The strains of S. flexneri shown were grown overnight in TSB, and the
proteins present in culture supernatants were trichloroacetic acid pre-
cipitated, separated on SDS–10% polyacrylamide gels, and stained
with Coomassie blue. The level of secretion of IpaB and IpaC is
compared to that for SF622 harboring pWPsf4 without an ipaC insert
(designated SF622) and SF622 harboring pWPsf4D for expressing
wild-type ipaD (IpaD). Wild-type S. flexneri M90T and S. flexneri
BS547 (mxiM mutant lacking a functional TTSS) were also included as
controls. The latter of these was performed in an experiment separate
from the one with all of the deletion mutations but with SF622, IpaD,
and M90T. The overall experiment was performed three times with
identical results.
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overall Ipa secretion but also in potentially fine-tuning the
hierarchy of the relative rates of IpaB and IpaC export.
IpaD does not control the size of the IpaB/IpaC pore in-
serted into target cell membranes. Since there is a reduction in
contact-mediated hemolysis activity for SF622 synthesizing
IpaD41–80 or IpaD81–120 relative to wild-type IpaD, it was
deemed important to determine whether the mutant forms of
IpaD were causing a change in the presentation of the IpaB/
IpaC complex to RBC. To accomplish this, a time course for
contact-mediated hemolysis by S. flexneri M90T and SF622
expressing ipaD, ipaD41-80, or ipaD81-120 was established
(Fig. 4). In these experiments, the time required to reach the
half-maximal level of contact-mediated hemolysis by a partic-
ular Shigella strain (defined here as t1/2) was determined for
SF622 expressing wild-type ipaD and SF622 expressing the
ipaD deletion mutations still capable of allowing hemolysis. As
shown in Fig. 4, each mutant form of IpaD resulted in a slowed
kinetics of contact-mediated hemolysis (the t1/2 for M90T and
SF622 synthesizing wild-type IpaD is 9 min, and the t1/2 for
the IpaD41–80 and IpaD81–120 mutants is about 17 min),
which could, in part, explain the reduced amount of total
hemolysis observed at the end of the assay. However, at this
point we could not exclude the possibility that the mutant
forms of IpaD resulted in an altered form of the IpaB/IpaC
complex inserted into the RBC membranes.
Introduction of Ipa pores into RBC membranes leads to lysis
that is detected by measuring the release of hemoglobin fol-
lowing osmotic shock (3, 31). It is possible to prevent lysis by
adding molecules that are large enough to be unable to pass
through the pore. These molecules counter the increased in-
ternal pressure generated within the erythrocytes following
pore insertion (3), thereby serving as osmotic protection
agents. For Ipa pores introduced by wild-type S. flexneri or by
SF622 expressing wild-type ipaD, molecules larger than those
of PEG2000 result in significant (greater than 50%) levels of
protection against hemolysis (Fig. 5). These data have been
shown to correspond to a pore size of about 2.5 to 3.0 nm (3).
When these experiments were analyzed as previously described
(3) to determine pore size, the IpaD41–80 and IpaD81–120
mutant strains gave rise to 2.80- and 2.90-nm pores, respec-
tively, while the wild-type strain generated a 2.85-nm pore.
These values are all within the range established previously (3),
i.e., 2.6  0.4 nm, and argue strongly that the N-terminal IpaD
mutations do not affect pore size.
IpaB and IpaC associate with erythrocyte membranes less
efficiently in the presence of IpaD41–80 and IpaD80–120. To
more carefully examine the reason why N-terminal IpaD mu-
tations give rise to reduced contact-mediated hemolysis, whole
erythrocyte membranes were prepared following a typical he-
molysis assay and the amount of IpaB and IpaC associated with
those membranes was determined by immunoblot analysis. As
shown in Fig. 6, S. flexneri M90T (wild type) and SF622 har-
boring a plasmid for the expression of wild-type ipaD insert
nearly equal amounts of IpaB and IpaC into the RBC mem-
branes. In contrast, SF622 expressing either ipaD41-80 or
ipaD81-120 inserts IpaB and IpaC much less efficiently (Fig. 6).
In fact, it is estimated that there is less than a 1/10 of the
amount of IpaB and IpaC introduced into the RBC by the
ipaD41-80 and ipaD81-120 mutants than there is by either
M90T or SF622 expressing wild-type ipaD. No IpaD was found
associated with the RBC membranes in any of these experi-
ments (data not shown). The amount of total proteins in the
RBC membrane fraction is the same in each case, as deter-
mined by the method of Bradford (5). Taken together, the data
suggest that the invasion deficiency caused by elimination of
ipaD is due to an inability of IpaB and IpaC to be presented to
FIG. 4. Kinetics of contact-mediated hemolysis by S. flexneri. A
typical contact-mediated hemolysis reaction was performed, and the
extent of hemoglobin release was monitored as a function of time (up
to 60 min). The percentage of hemolysis was determined for wild-type
S. flexneri M90T (filled triangles) or S. flexneri SF622 expressing ipaD
(open circles), ipaD41-80 (closed squares), or ipaD81-120 (open squares).
Negative controls included S. flexneri SF622 harboring pWPsf4 (no ipaD
insert; filled circles) and S. flexneri BS547 (defective TTSS; open tri-
angles). Complete hemolysis was determined by the addition of water.
The values shown are the average of triplicates ( the standard devia-
tion) and are from a representative experiment performed three times.
FIG. 5. Influence of different-sized osmoprotectants on the ability
for S. flexneri expressing different forms of ipaD to lyse RBC. A typical
contact-mediated hemolysis reaction was performed in the presence of
different osmoprotectants with wild-type S. flexneri M90T (open cir-
cles) or S. flexneri SF622 expressing ipaD (filled circles), ipaD41-80
(filled triangles), or ipaD81-120 (open triangles). Hemolysis in the ab-
sence of osmoprotectant is indicated by PBS, and all of the values
shown are relative to complete hemolysis, such as that which occurs
with the addition of water. The values shown are an average of tripli-
cates  the standard deviation (n 	 3) from a single experiment per-
formed three times.
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target cells and is not explained solely by constitutive secretion
of IpaB and IpaC. Indeed, the constitutive-secretion pheno-
type appears to have a relatively minor effect on invasion
efficiency, as indicated by the IpaD41–80 and IpaD81–120 phe-
notypes. Moreover, while the constitutive secretion of these
proteins alone could solely account for the reduction in con-
tact-mediated hemolysis, this is not supported by data from
SF622 expressing ipaD161-180, which secretes at levels more
closely resembling those of SF622 expressing ipaD but is still
completely noninvasive and completely incapable of contact-
mediated hemolysis (Table 2).
DISCUSSION
Until now, it has been generally accepted that IpaD’s pri-
mary function in Shigella invasion is to associate with IpaB
within the context of the Mxi/Spa type III secreton to form a
plug that prevents or controls the release of the remaining
Shigella effectors prior to pathogen contact with a host cell
(21). Following activation of the Shigella TTSS, IpaB and IpaC
form a translocon pore in the host cell membrane (3, 4). As an
integral component of the translocon (3), IpaC may directly
initiate the cytoskeletal rearrangements responsible for Shi-
gella entry (18, 31, 36). Similarly, IpaB triggers apoptosis in
macrophages (6) and may mediate host cell responses via in-
teractions with CD44 (35). In contrast, IpaD is required for
invasion, but it has not been implicated in triggering any spe-
cific events in host cells. Recently, it was proposed that IpaD
may be involved in delivering IpaB into target cell membranes
to initiate formation of the membrane-imbedded Ipa translo-
con, which then allows the passage of early effectors (IpaA,
IpgD) into the host cytoplasm while directly generating the
signals needed for initial subversion of the host cytoskeleton
(3, 35). This hypothesis assigns a direct role to IpaD in trans-
locon formation and would explain why ipaD mutants are com-
pletely unable to invade cultured cells or lyse RBC. IpaD’s
ability to direct IpaB insertion into RBC membranes in the
absence of IpaC would explain why ipaC mutants retain mea-
surable background levels (10%) of hemolysis activity but are
totally incapable of entering cultured cells (4). Meanwhile,
ipaB mutants completely lack contact-mediated hemolysis ac-
tivity, suggesting that IpaD is not capable of directly inserting
IpaC into RBC membranes (4). However, the latter observa-
tions could also be explained by the loss of secretion control in
ipaD and ipaB mutants, which could potentially cause deple-
tion of the IpaB/IpaC stores within the bacterial cytoplasm,
thereby preventing it from being available for insertion into
RBC membranes (21).
This study represents the first detailed investigation of
IpaD’s potential role in the invasion of target cells. Deletion of
the immediate N terminus of IpaD (amino acids 1 to 20)
eliminates its export via the Shigella TTSS, its ability to control
IpaB and IpaC secretion, and its ability to restore invasiveness
and contact-mediated hemolysis activities to S. flexneri SF622.
This suggests that IpaD’s invasion function occurs after it has
entered or exited the Mxi/Spa secreton. This is consistent with
the original hypothesis that IpaD’s major role in host cell
invasion is to serve as an external plug within the secreton.
Other deletions near the IpaD N terminus had no adverse
effects on IpaD secretion and only partial effects on the resto-
ration of invasiveness and contact-mediated hemolysis to
SF622. However, these mutations still eliminated IpaD’s ability
to control IpaB and IpaC secretion. All deletions downstream
of amino acid 120 completely eliminated IpaD’s ability to re-
store invasiveness, contact-mediated hemolysis, and control of
IpaB/IpaC secretion to SF622. Taken together, these data
show that IpaD’s essential role in target cell invasion can be
uncoupled from its ability to plug Ipa secretion. We find it
intriguing that that nearly all of the 20- to 40-amino-acid de-
letions made in IpaD led to deregulated Ipa secretion, and we
therefore propose that secretion regulation involves sensing
the folding of the entire protein.
Of particular interest with respect to IpaD’s role in hemo-
lysis and cell invasion is that IpaD41–80 and IpaD81–120 re-
store a significant, albeit reduced, level of invasion and con-
tact-mediated hemolysis activity to SF622. The reduction
in contact-mediated hemolysis activity for SF622 expressing
ipaD41-80 or ipaD81-120 could be accounted for by a reduction
in the number of IpaB/IpaC molecules or pores inserted into
the target cell membrane. However, the kinetics of RBC lysis
by SF622 expressing ipaD41-80 or ipaD81-120 suggest that
these mutants give rise not only to fewer translocons being
inserted into target cells but also to a delay in reaching maxi-
mal translocon insertion. This reduced number of translocons
would still be largely capable of triggering host cell signal
transduction events to allow invasion, but the reduced number
of IpaB-IpaC pores inserted into the host cell membrane
would lead to a reduced rate of pathogen escape into the host
cell cytoplasm, slowing intracellular growth and intercellular
spread. This is supported by the plaque assay data showing that
SF622 expressing ipaD81-120 produces plaques on BHK cell
monolayers that are smaller than those produced by SF622
expressing wild-type ipaD, although this does not appear to be
the case for SF622 expressing ipaD41-80, perhaps simply be-
cause it has a slightly higher pore insertion rate. Taken to-
gether, the accumulated invasion data suggest that IpaD41–80
and IpaD81–120 lead to reduced invasion efficiency for SF622,
where the lowest level of invasion efficiency was obtained when
quantifying the number of bacteria released following lysis of
FIG. 6. IpaD controls the efficiency of IpaB and IpaC insertion into
erythrocyte membranes. The amount of IpaB and IpaC present in
prepared RBC membranes was determined by immunoblot analysis
with anti-IpaB and anti-IpaC antibodies. M90T (lane 1) and SF622
expressing ipaD (lane 2) inserted similar amounts of these proteins
into the membranes. In contrast, SF622 expressing ipaD41-80 or
ipaD81-120 inserted much lower levels of IpaB and IpaC into the
membranes (lanes 3 and 4, respectively). SF622 not producing any
IpaD failed to insert detectable amounts of IpaB or IpaC into these
membranes (lane 6), as did the mxiD TTSS apparatus mutant (lane 5)
(1, 33). This experiment was performed three times with similar re-
sults.
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the host cells. However, this observation could be influenced
by differences in the intracellular growth rates of SF622 ex-
pressing the different forms of ipaD during the invasion and
gentamicin wash steps (possibly a result of different rates of
vacuolar escape).
Although there is no sequence homology between IpaD and
Yersinia LcrV, these two proteins have important functional
homology with respect to controlling translocon component
secretion, effector secretion, and the formation of the resulting
translocon channel (9, 19, 24, 25, 32). Likewise, LcrV has been
detected on the Yersinia cell surface prior to Yop secretion
(29) as IpaD has been reported to be partially exposed on the
surface of S. flexneri cells (21, 38). It is interesting that the
residues of IpaD that were reported to be surface exposed by
Turbyfill and colleagues (spanning amino acids 30 to 122) (38)
are nearly identical to those that can be deleted from IpaD to
reduce its ability to restore invasiveness and contact-mediated
hemolysis activity to SF622. Furthermore, the atomic structure
of LcrV was recently solved (8) and found to contain a long
central coiled-coil motif, which is readily identified within the
predicted secondary structure of PcrV/IpaD/SipD with avail-
able algorithms. Unfortunately, a great deal also remains to be
learned about the function of LcrV in Yersinia interactions
with host cells.
It was recently shown that when PcrV of Pseudomonas
aeruginosa is used to replace Yersinia LcrV, the resulting
YopB/YopD translocon pore has a slightly reduced inner di-
ameter (13), indicating that the size of the translocon pore can
be specifically regulated. When a similar swap experiment was
carried out with Salmonella SipD, which has significant se-
quence homology with IpaD (15), SipD was found to be inca-
pable of replacing IpaD for Shigella entry, contact-mediated
hemolysis, or control of IpaB and IpaC secretion (W. L. Pick-
ing and M. A. Baxter, unpublished results). On the basis of the
observations described here with different IpaD deletion mu-
tants, it seems likely that even if sipD expression in shigellae
resulted in altered Ipa pore size or number, it should still result
in some degree of Shigella uptake. Therefore, it appears that,
unlike for PcrV and LcrV, IpaD and SipD are not functionally
interchangeable.
After performing osmoprotection experiments, it was deter-
mined that IpaD41–80 and IpaD81–120 lead to the insertion of
IpaB/IpaC pores that are identical in size to those formed in
the presence of wild-type IpaD. However, the total amount of
IpaB and IpaC that is inserted into RBC membranes by these
IpaD mutants is greatly reduced with respect to that seen
with wild-type S. flexneri or SF622 expressing full-length ipaD.
While it is possible that depletion of cytoplasmic stores of IpaB
and IpaC could be responsible for the reduced efficiency of Ipa
translocon insertion into target cell membranes, this does not
turn out to be the case (K. Komoriya et al., unpublished data).
On the basis of the data presented here, it is more likely that
IpaD has a role in controlling the efficiency with which IpaB
and IpaC are physically inserted into target cell membranes.
This is similar to the recent findings of Goure and colleagues,
who found that P. aeruginosa PcrV has an important role in the
formation of the PopB/PopD translocation pore in target cells
(10).
The data presented here implicate IpaD as having an im-
portant role in targeting the Shigella effectors IpaB and IpaC to
the plasma membrane of target cells for translocon formation.
An additional IpaD function is control of IpaB and IpaC se-
cretion; however, this particular activity does not appear to be
essential for cellular invasion, at least in vitro. Instead, control
of secretion may be an energy-conserving function that ensures
maximal invasion efficiency in the human colon, where regu-
lation of the later stages of infection is critical. It is also likely
that efficient insertion of IpaB-IpaC pores is needed for max-
imum disruption of the phagosome immediately following en-
try. What remains to be determined is how IpaD exerts its
function. Whether IpaD ever physically associates with the
IpaB/IpaC complex is not clear; however, it is evident that
IpaD has a role in the invasion of intestinal epithelial cells that
extends well beyond its ability to control Ipa protein secretion.
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